Analysts Set C4 Therapeutics, Inc. (NASDAQ:CCCC) Price Target at $10.00
C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) has earned a consensus recommendation of “Hold” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month target price among brokerages […]
30 Nov 10:30 · The Markets Daily